Cambridge, MA J. Calnan & Associates, Inc. (JC&A), one of the leading construction management firms in the Northeast specializing in world-class pre-construction services and challenging construction projects, completed MassBioHub, MassBio’s new conference and business center.
Located at 700 Technology Sq., the MassBioHub is a unique and flexible space to accommodate groups of 2-200 for all your business needs, from informal staff huddles to full-scale conferences and corporate events. From 1:1 interviews to large scale conferences, MassBioHub is equipped with state-of-the-art audio/visual technology to help produce a seamless and successful virtual event, or hold a COVID-19 compliant meeting safely and without added stress.
JC&A collaborated with TRIA, Inc., Alexandria Real Estate Equities, RW Sullivan and Fort Point Project Management on this exciting project that will allow scientists to focus on what they do best – improving patient lives.
The team integrated new A/V, security, tel-data, and lighting control for the space and installed a sound masking system to eliminate existing building noise. Designed to support networking and breakout opportunities, the space features multiple communal areas and an interconnecting black steel staircase with hand crafted Corian and pressure treated wood.
As companies are currently reconfiguring office and lab space to support social distancing, hosting a small meeting or event becomes near impossible due to space constraints. MassBioHub has the space and all the technology to ensure virtual events and meetings are engaging, professional and supports the evolving business needs of our Life Sciences community.
“It was an absolute pleasure to work with JC&A for the construction of MassBio’s new conference and business center. The team impressed us every step of the way with their responsiveness, attention to detail, and ability to stay focused on the client and project even through the COVID-19 pandemic. We could not be happier with the new space and look forward to a long partnership with JC&A,” said president and CEO of MassBio, Bob Coughlin.
“We are proud to be part of this important project for MassBio,” said Jay Calnan, CEO of JC&A. “In the end, it’s all about improving patients’ lives, and this new headquarters will allow the Life Sciences community to further advance their therapies.”
The project team includes: